97 Matching Annotations
  1. Oct 2026
    1. 31

      Case31: 2 mo (at biopsy), Indian

      Case 31 (Level 2)


      CasePreviousTesting: same as group. found 0.7 nmol/mg protein/18 h propionate incorporation, 1.9 nmol/mg/protein/18 h propionate incorporation with hydroxocobalamin supplementation

      CaseMethod1: same as group

      CaseMethod2: same as group

      CaseGenotypingMethod: same as group


      Variant1: NM_000255.3:c.257C>T (p.Pro86Leu)

      ClinVar: 553773

      CAID: CA3847150

      gnomAD: 0.00009799 (South Asian)


      CaseAddInfo: mut- type, homozygous mutations. documented consanguinity.

    2. 30

      Case30: 6 wks (at biopsy), Pakistani

      Case 30 (Level 2)


      CasePreviousTesting: same as group. found 0.8 nmol/mg protein/18 h propionate incorporation, 0.7 nmol/mg/protein/18 h propionate incorporation with hydroxocobalamin supplementation

      CaseMethod1: same as group

      CaseMethod2: same as group

      CaseGenotypingMethod: same as group


      Variant1: NM_000255.3:c.55dupG (p.Val19Glyfs)

      ClinVar: 222906

      CAID: CA10575888

      gnomAD: n/a


      CaseAddInfo: mut0 type, homozygous mutations. novel variant.

    3. 28

      Case28: 1 y 1 mo (at biopsy), European

      Case 28 (Level 2)


      CasePreviousTesting: same as group. found 1.1 nmol/mg protein/18 h propionate incorporation, 1.2 nmol/mg/protein/18 h propionate incorporation with hydroxocobalamin supplementation

      CaseMethod1: same as group

      CaseMethod2: same as group

      CaseGenotypingMethod: same as group


      Variant1: NM_000255.3:c.1181dupT (p.Leu394Phefs)

      ClinVar: 222930

      CAID: CA10575868

      gnomAD: n/a


      Variant2: NM_000255.3:c.1975C>T (p.Gln659Ter)

      ClinVar: 222939

      CAID: CA10575859

      gnomAD: n/a


      CaseAddInfo: mut0 type. both novel mutations. heterozygous mutations, unknown cis or trans.

    4. 27

      Case27: no age or ethnicity recorded

      Case 27 (Level 2)


      CasePreviousTesting: same as group. found 0.4 nmol/mg protein/18 h propionate incorporation, 0.4 nmol/mg/protein/18 h propionate incorporation with hydroxocobalamin supplementation

      CaseMethod1: same as group

      CaseMethod2: same as group

      CaseGenotypingMethod: same as group


      Variant1: NM_000255.3:c.1061delCinsGGA (p.Ser354TrpfsTer20)

      ClinVar: n/a

      CAID: CA913187308

      gnomAD: n/a


      Variant2: NM_000255.3:c.1065_1068dupATGG (p.Ser357MetfsTer5)

      ClinVar: 280817

      CAID: CA10602989

      gnomAD: n/a


      CaseAddInfo: mut0 type. both novel mutations. heterozygous mutations. Examination of NGS reads determined mutations are in trans

    5. 26

      Case26: 7 y (at biopsy), Hispanic

      Case 26 (Level 2)


      CasePreviousTesting: same as group. found 4.5 nmol/mg protein/18 h propionate incorporation, 7.2 nmol/mg/protein/18 h propionate incorporation with hydroxocobalamin supplementation

      CaseMethod1: same as group

      CaseMethod2: same as group

      CaseGenotypingMethod: same as group


      Variant1: NM_000255.3:c.970G>A (p.Ala324Thr)

      ClinVar: 550893

      CAID: CA364400785

      gnomAD: 0.0001632 (Other)


      Variant2: NM_000255.3:c.1846C>T (p.Arg616Cys)

      ClinVar: 551499

      CAID: CA3846722

      gnomAD: 0.00008688 (Latino)


      CaseAddInfo: mut- type, heterozygous mutations, unknown cis or trans. Protein change in paper (p.P649L) is different than protein change indicated by clin var and CAID (p.Arg616Cys).

    6. 29

      Case29: 3 mo (at biopsy), Chinese

      Case 29 (Level 2)


      CasePreviousTesting: same as group. found 0.3 nmol/mg protein/18 h propionate incorporation, 0.6 nmol/mg/protein/18 h propionate incorporation with hydroxocobalamin supplementation

      CaseMethod1: same as group

      CaseMethod2: same as group

      CaseGenotypingMethod: same as group


      Variant1: NM_000255.3:c.1280G>A (p.Gly427Asp)

      ClinVar: 218990

      CAID: CA347873

      gnomAD: 0.0004011 (East Asian)


      Variant2: Exon 13 deletion

      ClinVar: n/a

      CAID: n/a

      gnomAD: n/a


      CaseAddInfo: Variant 2 is novel. Heterozygous mutations in MUT, unknown cis or trans. Additional variant found in TCN2 gene (NM_000355.3:c.509G>A, ClinVar: 341197, CAID: CA10184685, gnomAD: 0.007469 (East Asian)). heterozygous Exon 13 deletion confirmed by microarray-based comparative genomic hybridization.

    7. 25

      Case25: 25 y (at biopsy), White

      Case 25 (Level 2)


      CasePreviousTesting: same as group. found 1.3 nmol/mg protein/18 h propionate incorporation, 1.2 nmol/mg/protein/18 h propionate incorporation with hydroxocobalamin supplementation

      CaseMethod1: same as group

      CaseMethod2: same as group

      CaseGenotypingMethod: same as group


      Variant1: NM_000255.3:c.935G>T (p.Gly312Val)

      ClinVar: 218988

      CAID: CA347874

      gnomAD: n/a


      Variant2: NM_000255.3:c.1909G>A (p.Gly637Arg)

      ClinVar: n/a

      CAID: CA3846712

      gnomAD: [0.000008798] (http://insert-your-link-here.com)(European non-Finnish)


      CaseAddInfo: mut0 type, heterozygous mutations, unknown cis or trans.

    8. 24

      Case24: no age or ethnicity recorded

      Case 24 (Level 2)


      CasePreviousTesting: same as group. found 0.4 nmol/mg protein/18 h propionate incorporation, 0.4 nmol/mg/protein/18 h propionate incorporation with hydroxocobalamin supplementation

      CaseMethod1: same as group

      CaseMethod2: same as group

      CaseGenotypingMethod: same as group


      Variant1: NM_000255.3:c.795_796insT or NM_000255.3:c.795dupT (p.Met266TyrfsTer7)

      ClinVar: n/a

      CAID: CA913187322

      gnomAD: n/a


      Variant2: NM_000255.3:c.1207C>T (p.Arg403Ter)

      ClinVar: 167310

      CAID: CA234287

      gnomAD: 0.0001602 (African)


      CaseAddInfo: Variant 1 is novel. Mut0 type, heterozygous mutations, unknown cis or trans.

    9. 23

      Case23: 3 mo (at biopsy), French Canadian

      Case 23 (Level 2)


      CasePreviousTesting: same as group. found 1.4 nmol/mg protein/18 h propionate incorporation, 1.3 nmol/mg/protein/18 h propionate incorporation with hydroxocobalamin supplementation

      CaseMethod1: same as group

      CaseMethod2: same as group

      CaseGenotypingMethod: same as group


      Variant1: NM_000255.3:c.753+3A>G

      ClinVar: n/a

      CAID: CA3847056

      gnomAD: 0.000008890 (European non-Finnish)


      Variant2: NM_000255.3:c.1332+1delG

      ClinVar: 554656

      CAID: CA3846920

      gnomAD: 0.000008828 (European non-Finnish)


      CaseAddInfo: mut0 type, heterozygous mutations, unknown cis or trans. Variant 1 is novel.

    10. 22

      Case22: 28 mo (at biopsy), Korean

      Case 22 (Level 2)


      CasePreviousTesting: same as group. found 0.8 nmol/mg protein/18 h propionate incorporation, 0.8 nmol/mg/protein/18 h propionate incorporation with hydroxocobalamin supplementation

      CaseMethod1: same as group

      CaseMethod2: same as group

      CaseGenotypingMethod: same as group


      Variant1: NM_000255.3:c.682C>T (p.Arg228Ter)

      ClinVar: 203855

      CAID: CA312778

      gnomAD: 0.0002615 (Latino)


      Variant2: NM_000255.3:c.1481T>A (p.Leu494Ter)

      ClinVar: 551275

      CAID: CA3846864

      gnomAD: 0.0001088 (East Asian)


      CaseAddInfo: mut0 type, heterozygous mutations, unknown cis or trans

    11. 21

      Case21: 2 mo (at biopsy), White

      Case 21 (Level 2)


      CasePreviousTesting: same as group. found 0.6 nmol/mg protein/18 h propionate incorporation, 0.6 nmol/mg/protein/18 h propionate incorporation with hydroxocobalamin supplementation

      CaseMethod1: same as group

      CaseMethod2: same as group

      CaseGenotypingMethod: same as group


      Variant1: NM_000255.3:c.682C>T (p.Arg228Ter)

      ClinVar: 203855

      CAID: CA312778

      gnomAD: 0.0002615 (Latino)


      Variant2: NM_000255.3:c.1287C>G (p.Tyr429Ter)

      ClinVar: 554278

      CAID: CA364398724

      gnomAD: 0.00006483 (European non-Finnish)


      CaseAddInfo: mut0 type, heterozygous mutations, unknown cis or trans.

    12. 20

      Case20: 5 days (at biopsy), White

      Case 20 (Level 2)


      CasePreviousTesting: same as group. found 2.1 nmol/mg protein/18 h propionate incorporation, 1.9 nmol/mg/protein/18 h propionate incorporation with hydroxocobalamin supplementation

      CaseMethod1: same as group

      CaseMethod2: same as group

      CaseGenotypingMethod: same as group


      Variant1: NM_000255.3:c.682C>T (p.Arg228Ter)

      ClinVar: 203855

      CAID: CA312778

      gnomAD: 0.0002615 (Latino)


      Variant2: NM_000255.3:c.1106G>A (p.Arg369His)

      ClinVar: 203846

      CAID: CA312764

      gnomAD: 0.0001504 (East Asian)


      CaseAddInfo: mut0 type, heterozygous mutations, unknown cis or trans.

    13. 19

      Case19: 1 mo (at biopsy), White

      Case 19 (Level 2)


      CasePreviousTesting: same as group. found 1.2 nmol/mg protein/18 h propionate incorporation, 1.0 nmol/mg/protein/18 h propionate incorporation with hydroxocobalamin supplementation

      CaseMethod1: same as group

      CaseMethod2: same as group

      CaseGenotypingMethod: same as group


      Variant1: NM_000255.3:c.655A>T (p.Asn219Tyr)

      ClinVar: 1886

      CAID: CA249731

      gnomAD: 0.0001318 (European non-Finnish)


      Variant2: NM_000255.3:c.1332+1delG

      ClinVar: 554656

      CAID: CA3846920

      gnomAD: 0.000008828 (European non-Finnish)


      CaseAddInfo: mut0 type, heterozygous mutations, unknown cis or trans

    14. 18

      Case18: 2 mo (at biopsy), French Canadian

      Case 18 (Level 2)


      CasePreviousTesting: same as group. found 0.7 nmol/mg protein/18 h propionate incorporation, 0.7 nmol/mg/protein/18 h propionate incorporation with hydroxocobalamin supplementation

      CaseMethod1: same as group

      CaseMethod2: same as group

      CaseGenotypingMethod: same as group


      Variant1: NM_000255.3:c.655A>T (p.Asn219Tyr)

      ClinVar: 1886

      CAID: CA249731

      gnomAD: 0.0001318 (European non-Finnish)

      __

      Variant2: NM_000255.3:c.1240delG (p.Glu414LysfsTer17)

      ClinVar: n/a

      CAID: CA3846936

      gnomAD: 0.000008796 (European Non-Finnish)


      CaseAddInfo: mut0 type. Variant 2 is novel. heterozygous mutations, unknown cis or trans.

    15. 17

      Case17: 6 y (at biopsy), Black

      Case 17 (Level 2)


      CasePreviousTesting: same as group. found 0.6 nmol/mg protein/18 h propionate incorporation, 0.6 nmol/mg/protein/18 h propionate incorporation with hydroxocobalamin supplementation

      CaseMethod1: same as group

      CaseMethod2: same as group

      CaseGenotypingMethod: same as group


      Variant1: NM_000255.3:c.631_633delGAG (p.Glu211del)

      ClinVar: n/a

      CAID: CA913187321

      gnomAD: n/a


      Variant2: NM_000255.3:c.682C>T (p.Arg228Ter)

      ClinVar: 203855

      CAID: CA312778

      gnomAD: 0.0002615 (Latino)


      CaseAddInfo: mut0 type, heterozygous mutations. Variant 1 is novel. MUT mutations are in trans- demonstrated by RT-PCR of mRNA. Additional variant found in MCEE gene (NM_032601.3:c.428G>A, ClinVar: 336936, CAID: CA1702575, gnomAD: 0.08102 (Latino)) MCEE variant is unlikely to be associated with patient's MMA.

    16. 16

      Case16: 5 days (at biopsy), Lao/Thai/Mexican/Portugese

      Case 16 (Level 2)


      CasePreviousTesting: same as group. found 0.6 nmol/mg protein/18 h propionate incorporation, 0.5 nmol/mg/protein/18 h propionate incorporation with hydroxocobalamin supplementation

      CaseMethod1: same as group

      CaseMethod2: same as group

      CaseGenotypingMethod: same as group


      Variant1: NM_000255.3:c.581C>T (p.Pro194Leu)

      ClinVar: n/a

      CAID: CA364404418

      gnomAD: n/a


      Variant2: NM_000255.3:c.682C>T (p.Arg228Ter)

      ClinVar: 203855

      CAID: CA312778

      gnomAD: 0.0002615 (Latino)


      CaseAddInfo: mut0 type, heterozygous mutation, unknown cis or trans

    17. 15

      Case15: 3 wks (at biopsy), white

      Case (Level 2)


      CasePreviousTesting: same as group. found 0.5 nmol/mg protein/18 h propionate incorporation, 0.7 nmol/mg/protein/18 h propionate incorporation with hydroxocobalamin supplementation

      CaseMethod1: same as group

      CaseMethod2: same as group

      CaseGenotypingMethod: same as group


      Variant1: NM_000255.3:c.572C>A (p.Ala191Glu)

      ClinVar: 203854

      CAID: CA312777

      gnomAD: 0.00006976 (European non-FInnish)


      Variant2: NM_000255.3:c.754-2A>G

      ClinVar: 552691

      CAID: CA364402853

      gnomAD: n/a


      CaseAddInfo: variant 2 is a novel, splice site mutation. Heterozygous mutations, unknown cis or trans.

    18. 13

      Case13: 21 y (at biopsy), English/Irish

      Case (Level 2)


      CasePreviousTesting: same as group. found 1.5 nmol/mg protein/18 h propionate incorporation, 1.5 nmol/mg/protein/18 h propionate incorporation with hydroxocobalamin supplementation

      CaseMethod1: same as group

      CaseMethod2: same as group

      CaseGenotypingMethod: same as group


      Variant1: NM_000255.3:c.572C>A (p.Ala191Glu)

      ClinVar: 203854

      CAID: CA312777

      gnomAD: 0.00006976 (European non-FInnish)


      Variant2: NM_000255.3:c.682C>T (p.Arg228Ter)

      ClinVar: 203855

      CAID: CA312778

      gnomAD: 0.0002615 (Latino)


      CaseAddInfo: mut0 type, heterozygous mutation, unknown cis or trans

    19. 12

      Case12: 6y (at biopsy), no ethnicity recorded

      Case (Level 2)


      CasePreviousTesting: same as group. found 0.5 nmol/mg protein/18 h propionate incorporation, 1.3 nmol/mg/protein/18 h propionate incorporation with hydroxocobalamin supplementation

      CaseMethod1: same as group

      CaseMethod2: same as group

      CaseGenotypingMethod: same as group


      Variant1: NM_000255.3:c.556A>G (p.Met186Val)

      ClinVar: 551460

      CAID: CA3847093

      gnomAD: 0.00001760 (European Non-Finnish)


      Variant2: NM_000255.3:c.1106G>A (p.Arg369His)

      ClinVar: 203846

      CAID: CA312764

      gnomAD: 0.0001504 (East Asian)


      CaseAddInfo: mut- type, heterozygous mutations, unknown cis or trans

    20. 11

      Case11: 6y (at biopsy), White/Hispanic

      Case (Level 2)


      CasePreviousTesting: same as group. found 2.6 nmol/mg protein/18 h propionate incorporation, 7.0 nmol/mg/protein/18 h propionate incorporation with hydroxocobalamin supplementation

      CaseMethod1: same as group

      CaseMethod2: same as group

      CaseGenotypingMethod: same as group


      Variant1: NM_000255.3:c.566A>T (p.Asn189Ille)

      ClinVar: 222915

      CAID: CA3847091

      gnomAD: 0.000008804 (European Non-Finnish)


      Variant2: NM_000255.3:c.655A>T (p.Asn219Tyr)

      ClinVar: 1886

      CAID: CA249731

      gnomAD: 0.0001318 (European non-Finnish)


      CaseAddInfo: Variant 1 is novel, unknown cis or trans. mut- type.

    21. 14

      Case14: 3 mo (at biopsy), White/Australian

      Case (Level 2)


      CasePreviousTesting: same as group. found 0.5 nmol/mg protein/18 h propionate incorporation, 0.5 nmol/mg/protein/18 h propionate incorporation with hydroxocobalamin supplementation

      CaseMethod1: same as group

      CaseMethod2: same as group

      CaseGenotypingMethod: same as group


      Variant1: NM_000255.3:c.572C>A (p.Ala191Glu)

      ClinVar: 203854

      CAID: CA312777

      gnomAD: 0.00006976 (European non-FInnish)


      Variant2: NM_000255.3:c.682C>T (p.Arg228Ter)

      ClinVar: 203855

      CAID: CA312778

      gnomAD: 0.0002615 (Latino)


      CaseAddInfo: mut0 type, heterozygous mutation, unknown cis or trans

    22. 10

      Case10: 6 days (at biopsy), Northern European/Filipino

      Case (Level 2)


      CasePreviousTesting: same as group. found 0.8 nmol/mg protein/18 h propionate incorporation, 1.2 nmol/mg/protein/18 h propionate incorporation with hydroxocobalamin supplementation

      CaseMethod1: same as group

      CaseMethod2: same as group

      CaseGenotypingMethod: same as group


      Variant1: NM_000255.3:c.322C>T (p.Arg108Cys)

      ClinVar: 1887

      CAID: CA249732

      gnomAD: 0.0008393 (Latino)


      Variant2: NM_000255.3:c.682C>T (p.Arg228Ter)

      ClinVar: 203855

      CAID: CA312778

      gnomAD: 0.0002615 (Latino)


      CaseAddInfo: mut0 type, heterozygous mutations, unknown cis or trans.

    23. 9

      Case9: 46 days (at biopsy), Hispanic

      Case (Level 2)


      CasePreviousTesting: same as group. found 0.8 nmol/mg protein/18 h propionate incorporation, 1.2 nmol/mg/protein/18 h propionate incorporation with hydroxocobalamin supplementation

      CaseMethod1: same as group

      CaseMethod2: same as group

      CaseGenotypingMethod: same as group


      Variant1: NM_000255.3:c.322C>T (p.Arg108Cys)

      ClinVar: 1887

      CAID: CA249732

      gnomAD: 0.0008393 (Latino)


      Variant2: NM_000255.3:c.654A>C (p.Gln218His)

      ClinVar: 551243

      CAID: CA364404273

      gnomAD: 0.000008809 (European non-Finnish)


      CaseAddInfo: mut0 class, heterozygous mutations, unknown cis or trans.

    24. 8

      Case8: 12 days (at biopsy), White/Mexican

      Case (Level 2)


      CasePreviousTesting: same as group. found 0.8 nmol/mg protein/18 h propionate incorporation, 1.0 nmol/mg/protein/18 h propionate incorporation with hydroxocobalamin supplementation

      CaseMethod1: same as group

      CaseMethod2: same as group

      CaseGenotypingMethod: same as group


      Variant1: NM_000255.3:c.322C>T (p.Arg108Cys)

      ClinVar: 1887

      CAID: CA249732

      gnomAD: 0.0008393 (Latino)


      Variant2: NM_000255.3:c.654A>C (p.Gln218His)

      ClinVar: 551243

      CAID: CA364404273

      gnomAD: 0.000008809 (European non-Finnish)


      CaseAddInfo: mut0 class, heterozygous mutations, unknown cis or trans.

    25. 7

      Case7: 10 days (at biopsy), White

      Case (Level 2)


      CasePreviousTesting: same as group. found 0.4 nmol/mg protein/18 h propionate incorporation, 0.5 nmol/mg/protein/18 h propionate incorporation with hydroxocobalamin supplementation

      CaseMethod1: same as group

      CaseMethod2: same as group

      CaseGenotypingMethod: same as group


      Variant1: NM_000255.3:c.146_147ins279

      ClinVar: n/a

      CAID: n/a- could not register

      gnomAD: n/a


      Variant2: NM_000255.3:c.372_374dupGA (p.Lys124_Asp125insGlu)

      ClinVar: 203861

      CAID: CA312788

      gnomAD: 0.000008799


      CaseAddInfo: mut0 class. heterozygous mutations. identified to be in trans through cDNA analysis. variant 1 is novel and consists of a 279 base pair insertion.

    26. 6

      Case6 2 mo (at biopsy), White

      Case (Level 2)


      CasePreviousTesting: same as group. found 1.1 nmol/mg protein/18 h propionate incorporation, 3.0 nmol/mg/protein/18 h propionate incorporation with hydroxocobalamin supplementation

      CaseMethod1: same as group

      CaseMethod2: same as group

      CaseGenotypingMethod: same as group


      Variant1: NM_000255.3:c.129G>A (p.Trp43Ter)

      ClinVar: 222908

      CAID: CA10575886

      gnomAD: n/a


      Variant2: NM_000255.3:c.299A>G (p.Tyr100Cys)

      ClinVar: 218991

      CAID: CA347866

      gnomAD: 0.000008793 (European non-Finnish)


      CaseAddInfo: mut- class. heterozygous mutations. unknown cis or trans. variant 1 is novel.

    27. 5

      Case5: 1y 9 mo (at biopsy), Korean

      Case (Level 2)


      CasePreviousTesting: same as group. found 0.7 nmol/mg protein/18 h propionate incorporation, 0.7 nmol/mg/protein/18 h propionate incorporation with hydroxocobalamin supplementation

      CaseMethod1: same as group

      CaseMethod2: same as group

      CaseGenotypingMethod: same as group


      Variant1: NM_000255.3:c.91C>T (p.Arg31Ter)

      ClinVar: 92688

      CAID: CA249743

      gnomAD: 0.00008013 (African)


      Variant2: NM_000255.3:c.349G>T (p.Glu117Ter)

      ClinVar: 1882

      CAID: CA115264

      gnomAD: n/a


      CaseAddInfo: mut0 class. heterozygous mutations. unknown cis or trans.

    28. 4

      Case4: 2 y (at biopsy), Black

      Case (Level 2)


      CasePreviousTesting: same as group. found 2.1 nmol/mg protein/18 h propionate incorporation, 3.1 nmol/mg/protein/18 h propionate incorporation with hydroxocobalamin supplementation

      CaseMethod1: same as group

      CaseMethod2: same as group

      CaseGenotypingMethod: same as group


      Variant1: NM_000255.3:c.91C>T (p.Arg31Ter)

      ClinVar: 92688

      CAID: CA249743

      gnomAD: 0.00008013 (African)


      Variant2: NM_000255.3:c.323G>A (p.Arg108His)

      ClinVar: 100707

      CAID: CA235522

      gnomAD: 0.00006152 (African)


      CaseAddInfo: mut- class. heterozygous mutations. unknown cis or trans. Third variant in TCN2 gene (NM_000355.3:c.89T>G p.Leu30Arg, CAID: CA10184491, ClinVar: 529781, gnomAD: 0.01329 (African))

    29. 3

      Case3: 19y (at biopsy), Irish/Scottish/Polish

      Case (Level 2)


      CasePreviousTesting: same as group. found 1.2 nmol/mg protein/18 h propionate incorporation, 1.2 nmol/mg/protein/18 h propionate incorporation with hydroxocobalamin supplementation

      CaseMethod1: same as group

      CaseMethod2: same as group

      CaseGenotypingMethod: same as group


      Variant1: NM_000255.3:c.29dupT (p.Leu10PhefsTer39)

      ClinVar: 553287

      CAID: CA567155988

      gnomAD: 0.00003269 (South Asian)


      Variant2: NM_000255.3:c.1658delT (p.Val553GlyfsTer17)

      ClinVar: n/a

      CAID: CA450397348

      gnomAD: 0.000008808 (European non-Finnish)


      CaseAddInfo: mut0 class. heterozygous mutations. variant 1 is novel. unknown cis or trans.

    30. 2

      Case2: 1 mo (at biopsy), Palestinian

      Case (Level 2)


      CasePreviousTesting: same as group. found 1.5 nmol/mg protein/18 h propionate incorporation, 1.5 nmol/mg/protein/18 h propionate incorporation with hydroxocobalamin supplementation

      CaseMethod1: same as group

      CaseMethod2: same as group

      CaseGenotypingMethod: same as group


      Variant1: NM_000255.3:c.2T>C (p.Met1Thr)

      ClinVar: 222903

      CAID: CA10575890

      gnomAD: n/a


      Variant2: NM_000255.3:c.1630_1631delGGinsTA (p.Gly544Ter)

      ClinVar: 203860

      CAID: CA312786

      gnomAD: 0.0001088 (East Asian)


      CaseAddInfo: mut0 class. heterozygous mutations- unknown cis or trans. 3rd mutation in CD320 gene (NM_016579.3:c.658G>A p.Gly220Arg, ClinVar: 136684, CAID: CA289989, gnomAD: 0.3086 (African) )

    31. 1

      Case1: 13 mo (at biopsy), no recorded ethnicity

      Case (Level 2)


      CasePreviousTesting: same as group. found 2.4 nmol/mg protein/18 h propionate incorporation, 4.7 nmol/mg/protein/18 h propionate incorporation with hydroxocobalamin supplementation

      CaseMethod1: same as group

      CaseMethod2: same as group

      CaseGenotypingMethod: same as group


      Variant1: NM_000255.3:c.1A>G (p.M1?)

      ClinVar: n/a

      CAID: CA364406084

      gnomAD: n/a


      Variant2: NM_000255.3:c.2150G>T (p.Gly717Val)

      ClinVar: 1881

      CAID: CA249729

      gnomAD: 0.0006810 (African)


      CaseAddInfo: mut- class. heterozygous mutations. unknown cis or trans

    32. 48

      Case48: 8 mo (at biopsy), Indian

      Case 48 (Level 2)


      CasePreviousTesting: same as group. found 1.1 nmol/mg protein/18 h propionate incorporation, 1.1 nmol/mg/protein/18 h propionate incorporation with hydroxocobalamin supplementation

      CaseMethod1: same as group

      CaseMethod2: same as group

      CaseGenotypingMethod: same as group


      Variant1: NM_000255.3:c.2179C>T (p.Arg727Ter)

      ClinVar: 218998

      CAID: CA347913

      gnomAD: 0.0001504 (East Asian)


      CaseAddInfo: mut0 type, homozygous mutations.

    33. 47

      Case47: 2 y 7 mo (at biopsy), Barbadian

      Case 47 (Level 2)


      CasePreviousTesting: same as group. found 0.4 nmol/mg protein/18 h propionate incorporation, 1.3 nmol/mg/protein/18 h propionate incorporation with hydroxocobalamin supplementation

      CaseMethod1: same as group

      CaseMethod2: same as group

      CaseGenotypingMethod: same as group


      Variant1: NM_000255.3:c.2150G>T (p.Gly717Val)

      ClinVar: 1881

      CAID: CA249729

      gnomAD: 0.0006810 (African)


      CaseAddInfo: mut- type, homozygous mutations. reportedly non-consanguineous

    34. 46

      Case46: 1 y (at biopsy), White

      Case 46 (Level 2)


      CasePreviousTesting: same as group. found 1.0 nmol/mg protein/18 h propionate incorporation, 0.9 nmol/mg/protein/18 h propionate incorporation with hydroxocobalamin supplementation

      CaseMethod1: same as group

      CaseMethod2: same as group

      CaseGenotypingMethod: same as group


      Variant1: NM_000255.3:c.1962_1963delTC (p.Arg655Terfs)

      ClinVar: 552144

      CAID: CA658821515

      gnomAD: n/a


      CaseAddInfo: mut0 type, homozygous mutations.

    35. 44

      Case44: 13y (at biopsy), Arab

      Case 44 (Level 2)


      CasePreviousTesting: same as group. found 0.8 nmol/mg protein/18 h propionate incorporation, 1.1 nmol/mg/protein/18 h propionate incorporation with hydroxocobalamin supplementation

      CaseMethod1: same as group

      CaseMethod2: same as group

      CaseGenotypingMethod: same as group


      Variant1: NM_000255.3:c.1871A>G (p.Gln624Arg)

      ClinVar: n/a

      CAID: CA3846720

      gnomAD: 0.00003266 (South Asian)


      CaseAddInfo: mut0 type, homozygous mutations.

    36. 43

      Case43: 20 y (at biopsy), Lebanese

      Case 43 (Level 2)


      CasePreviousTesting: same as group. found 1.4 nmol/mg protein/18 h propionate incorporation, 1.1 nmol/mg/protein/18 h propionate incorporation with hydroxocobalamin supplementation

      CaseMethod1: same as group

      CaseMethod2: same as group

      CaseGenotypingMethod: same as group


      Variant1: NM_000255.3:c.1741C>T (p.Arg581Ter)

      ClinVar: 554675

      CAID: CA364395893

      gnomAD: n/a


      CaseAddInfo: mut0 type, homozygous mutations.

    37. 45

      Case45: no age or ethnicity recorded

      Case 45 (Level 2)


      CasePreviousTesting: same as group. found 1.5 nmol/mg protein/18 h propionate incorporation, 1.6 nmol/mg/protein/18 h propionate incorporation with hydroxocobalamin supplementation

      CaseMethod1: same as group

      CaseMethod2: same as group

      CaseGenotypingMethod: same as group


      Variant1: NM_000255.3:c.1891delG (p.Ala631GlinfsTer17)

      ClinVar: n/a

      CAID: CA351288

      gnomAD: 0.00002896 (Latino)


      CaseAddInfo: mut0 type, homozygous mutations.

    38. 42

      Case42: 1 y 7 mo (at biopsy), Hmong

      Case 42 (Level 2)


      CasePreviousTesting: same as group. found 4.5 nmol/mg protein/18 h propionate incorporation, 9.0 nmol/mg/protein/18 h propionate incorporation with hydroxocobalamin supplementation

      CaseMethod1: same as group

      CaseMethod2: same as group

      CaseGenotypingMethod: same as group


      Variant1: NM_000255.3:c.1663G>A (p.Ala555Thr)

      ClinVar: 203850

      CAID: CA312769

      gnomAD: 0.0003262 (East Asian)


      CaseAddInfo: mut- type, homozygous mutations. Additional heterozygous mutations in CUBN gene (Variant 1: NM_001081.3:c.3500G>T, CAID: CA376148913 , gnomAD: 0.00005014, East Asian ) (Variant 2: NM_001081.3:c.6211A>G, CAID: CA5423765 , gnomAD: 0.001003, East Asian )

    39. 41

      Case41: 6 mo (at biopsy), Pakistani

      Case 41 (Level 2)


      CasePreviousTesting: same as group. found 0.6 nmol/mg protein/18 h propionate incorporation, 0.6 nmol/mg/protein/18 h propionate incorporation with hydroxocobalamin supplementation

      CaseMethod1: same as group

      CaseMethod2: same as group

      CaseGenotypingMethod: same as group


      Variant1: NM_000255.3:c.1560G>C (p.Lys520Asn)

      ClinVar: n/a

      CAID: CA364397073

      gnomAD: n/a


      CaseAddInfo: mut0 type, homozygous mutations.

    40. 40

      Case40: Middle Eastern

      Case 40 (Level 2)


      CasePreviousTesting: same as group. found 1.8 nmol/mg protein/18 h propionate incorporation, 1.6 nmol/mg/protein/18 h propionate incorporation with hydroxocobalamin supplementation

      CaseMethod1: same as group

      CaseMethod2: same as group

      CaseGenotypingMethod: same as group


      Variant1: NM_000255.3:c.1420C>T (p.Arg474Ter)

      ClinVar: 554873

      CAID: CA138795916

      gnomAD: 0.00003267 (South Asian)


      CaseAddInfo: mut0 type, homozygous mutations. documented consanguinity.

    41. 39

      Case39: 1 y (at biopsy), Asian

      Case 39 (Level 2)


      CasePreviousTesting: same as group. found 1.4 nmol/mg protein/18 h propionate incorporation, 1.5 nmol/mg/protein/18 h propionate incorporation with hydroxocobalamin supplementation

      CaseMethod1: same as group

      CaseMethod2: same as group

      CaseGenotypingMethod: same as group


      Variant1: NM_000255.3:c.1280G>A (p.Gly427Asp)

      ClinVar: 218990

      CAID: CA347873

      gnomAD: 0.0004011 (East Asian)


      CaseAddInfo: mut0 type, homozygous mutations. documented non-consanguinity.

    42. 38

      Case38: 9 y (at biopsy), German/Polish

      Case 38 (Level 2)


      CasePreviousTesting: same as group. found 0.5 nmol/mg protein/18 h propionate incorporation, 0.5 nmol/mg/protein/18 h propionate incorporation with hydroxocobalamin supplementation

      CaseMethod1: same as group

      CaseMethod2: same as group

      CaseGenotypingMethod: same as group


      Variant1: NM_000255.3:c.1106G>A (p.Arg369His)

      ClinVar: 203846

      CAID: CA312764

      gnomAD: 0.0001504 (East Asian)


      CaseAddInfo: mut0 type, homozygous mutations.

    43. 37

      Case37: 18 mo (at biopsy), Moroccan

      Case 37 (Level 2)


      CasePreviousTesting: same as group. found 0.5 nmol/mg protein/18 h propionate incorporation, 0.5 nmol/mg/protein/18 h propionate incorporation with hydroxocobalamin supplementation

      CaseMethod1: same as group

      CaseMethod2: same as group

      CaseGenotypingMethod: same as group


      Variant1: NM_000255.3:c.683G>A (p.Arg228Gln)

      ClinVar: n/a

      CAID: CA3847070

      gnomAD: 0.00002905 (Latino)


      CaseAddInfo: mut0 type, homozygous mutations.

    44. 36

      Case36: 14 mo (at biopsy), Hispanic

      Case 36 (Level 2)


      CasePreviousTesting: same as group. found 0.7 nmol/mg protein/18 h propionate incorporation, 0.8 nmol/mg/protein/18 h propionate incorporation with hydroxocobalamin supplementation

      CaseMethod1: same as group

      CaseMethod2: same as group

      CaseGenotypingMethod: same as group


      Variant1: NM_000255.3:c.406G>T (p.Val136Phe)

      ClinVar: n/a

      CAID: CA364404792

      gnomAD: n/a


      CaseAddInfo: mut0 type, homozygous mutations. documented consanguinity.

    45. 35

      Case35: 5 y (at biopsy), Hispanic

      Case 35 (Level 2)


      CasePreviousTesting: same as group. found 0.5 nmol/mg protein/18 h propionate incorporation, 0.7 nmol/mg/protein/18 h propionate incorporation with hydroxocobalamin supplementation

      CaseMethod1: same as group

      CaseMethod2: same as group

      CaseGenotypingMethod: same as group


      Variant1: NM_000255.3:c.322C>T (p.Arg108Cys)

      ClinVar: 1887

      CAID: CA249732

      gnomAD: 0.0008393 (Latino)


      CaseAddInfo: mut0 type, homozygous mutations.

    46. 33

      Case33: 9 mo (at biopsy), Hispanic

      Case 33 (Level 2)


      CasePreviousTesting: same as group. found 1.0 nmol/mg protein/18 h propionate incorporation, 1.3 nmol/mg/protein/18 h propionate incorporation with hydroxocobalamin supplementation

      CaseMethod1: same as group

      CaseMethod2: same as group

      CaseGenotypingMethod: same as group


      Variant1: NM_000255.3:c.322C>T (p.Arg108Cys)

      ClinVar: 1887

      CAID: CA249732

      gnomAD: 0.0008393 (Latino)


      CaseAddInfo: mut0 type, homozygous mutations.

    47. 32

      Case32: 10 y (at biopsy), Arab

      Case 32 (Level 2)


      CasePreviousTesting: same as group. found 1.0 nmol/mg protein/18 h propionate incorporation, 1.0 nmol/mg/protein/18 h propionate incorporation with hydroxocobalamin supplementation

      CaseMethod1: same as group

      CaseMethod2: same as group

      CaseGenotypingMethod: same as group


      Variant1: NM_000255.3:c.278G>A (p.Arg93His)

      ClinVar: 1880

      CAID: CA249728

      gnomAD: 0.0004777 (European- Finnish)


      CaseAddInfo: mut0 type, homozygous mutations. documented consanguinity.

    48. 34

      Case34: 3.5 wks (at biopsy), White/Hispanic

      Case 34 (Level 2)


      CasePreviousTesting: same as group. found 1.6 nmol/mg protein/18 h propionate incorporation, 1.8 nmol/mg/protein/18 h propionate incorporation with hydroxocobalamin supplementation

      CaseMethod1: same as group

      CaseMethod2: same as group

      CaseGenotypingMethod: same as group


      Variant1: NM_000255.3:c.322C>T (p.Arg108Cys)

      ClinVar: 1887

      CAID: CA249732

      gnomAD: 0.0008393 (Latino)


      CaseAddInfo: mut0 type, homozygous mutations.

    1. P43

      Case43: Male, Chinese, 2.3y (end of study)

      HPOsFreeText: 2y onset, poor neurological outcome

      NotHPOsFreeText: not responsive to vitamin B12

      Case43 (Level 2)


      CasePreviousTesting: NBS

      CaseMethod1: same as group

      CaseMethod2: same as group

      CaseGenotypingMethod: same as group


      Variant1: NM_000255.3:c.2107G>A (p.Gly703Arg)

      ClinVar: n/a

      CAID: CA364394252

      gnomAD: 0.00006152 (African)


      CaseAddInfo: one variant, not homozygous.

    2. P42

      Case42: Female, Chinese, 2.3y (end of study)

      HPOsFreeText: 10 mo onset, poor neurological outcome

      NotHPOsFreeText: not responsive to vitamin B12

      Case42 (Level 2)


      CasePreviousTesting: same as group

      CaseMethod1: same as group

      CaseMethod2: same as group

      CaseGenotypingMethod: same as group


      Variant1: NM_000255.3:c.2080C>T (p.Arg694Trp)

      ClinVar: 218996

      CAID: CA347907

      gnomAD: 0.00006534 (South Asian)


      Variant2: NM_000255.3:c.2179C>T (p.Arg727Ter)

      ClinVar: 218998

      CAID: CA347913

      gnomAD: 0.0001504 (East Asian)


      CaseAddInfo: heterozygous mutations in trans.

    3. P41

      Case41: Male, Chinese, 10.3y (end of study)

      HPOsFreeText: 8.8y onset, poor neurological outcome

      NotHPOsFreeText: not responsive to vitamin B12

      Case41 (Level 2)


      CasePreviousTesting: same as group

      CaseMethod1: same as group

      CaseMethod2: same as group

      CaseGenotypingMethod: same as group


      Variant1: NM_000255.3:c.1790T>G (p.Ille597Arg)

      ClinVar: 551764

      CAID: CA364395663

      gnomAD: n/a


      Variant2: NM_000255.3:c.2106delA (p.VAl704Ter)

      ClinVar: 555523

      CAID: CA658821513

      gnomAD: n/a


      CaseAddInfo: both variants novel. heterozygous mutations in trans.

    4. P39

      Case39: Female, Chinese, 3.4y (end of study)

      HPOsFreeText: 1y onset, poor neurological outcome

      NotHPOsFreeText: not responsive to vitamin B12

      Case39 (Level 2)


      CasePreviousTesting: same as group

      CaseMethod1: same as group

      CaseMethod2: same as group

      CaseGenotypingMethod: same as group


      Variant1: NM_000255.3:c.1741C>T (p.Arg581Ter)

      ClinVar: 554675

      CAID: CA364395893

      gnomAD: n/a


      CaseAddInfo: one variant, not homozygous.

    5. P40

      Case40: Female, Chinese, 2.1y (end of study)

      HPOsFreeText: 8 mo onset, poor neurological outcome

      NotHPOsFreeText: not responsive to vitamin B12

      Case40 (Level 2)


      CasePreviousTesting: same as group

      CaseMethod1: same as group

      CaseMethod2: same as group

      CaseGenotypingMethod: same as group


      Variant1: NM_000255.3:c.1777G>T (p.Glu593Ter)

      ClinVar: 558328

      CAID: CA364395728

      gnomAD: n/a


      Variant2: NM_000255.3:c.2179C>T (p.Arg727Ter)

      ClinVar: 218998

      CAID: CA347913

      gnomAD: 0.0001504 (East Asian)


      CaseAddInfo: variant 1 is novel. heterozygous mutations in trans

    6. P38

      Case38: Male, Chinese, 1.5y (end of study)

      HPOsFreeText: neonatal onset, poor neurological outcome

      NotHPOsFreeText: not responsive to vitamin B12

      Case38 (Level 2)


      CasePreviousTesting: same as group

      CaseMethod1: same as group

      CaseMethod2: same as group

      CaseGenotypingMethod: same as group


      Variant1: NM_000255.3:c.1741C>T (p.Arg581Ter)

      ClinVar: 554675

      CAID: CA364395893

      gnomAD: n/a


      CaseAddInfo: one variant, not homozygous.

    7. twin sisters P35 and P36

      FamilyLabel: Family 1

      Family1PresentingHPOs: HP:0001987, HP:0001942, HP:0003128, HP:0002912 (hyperammonemia, metabolic acidosis, lactic acidosis, methylmalonic acidemia)

      NotHPOsFreeText: normal plasma total homocysteine

      CountryOrigin: China

      Ethnicity: Chinese

      ProbandLabel: Case35, Case36

      Family1 (Level 2)


      FamilyPreviousTesting: tandem mass spectrometry for blood levels, gas chromatography-mass spectrometry for urine, NBS

      FamilyMethod1: PCR

      FamilyGenotypingMethod: genomic DNA extracted from peripheral blood leukocytes from patients and their parents. Exonic ad flanking intronic regions of the MUT gene were amplified through PCR. PCR products were sequenced directly using forward and reverse primers on ABI 3700 sequencer. Mutation analysis using MUT reference NM_000255.3. Nucleotide numbering reflects cDNA numbering (initiation codon= codon1). All detected mutations were confirmed in the patients' parents. Novel variants were screened in 100 alleles from 50 control children. Novel variants were considered pathogenic when predicted to be deleterious by two algorithms.

      FamilyAddInfo: counted in group annotation also. identical twins. mut- and mut0 mutation together may explain relatively good clinical condition.

    8. P37

      Case37: Female, Chinese, 5.8y (end of study)

      HPOsFreeText: 3y onset

      NotHPOsFreeText: normal cognitive and motor development without further episodes of metabolic decompensation, not responsive to vitamin B12

      Case37 (Level 2)


      CasePreviousTesting: same as group

      CaseMethod1: same as group

      CaseMethod2: same as group

      CaseGenotypingMethod: same as group


      Variant1: NM_000255.3:c.1677-1G>A (p.=)

      ClinVar: 550012

      CAID: CA3846767

      gnomAD: 0.0003511 (East Asian)


      CaseAddInfo: one variant, not homozygous

    9. P36

      Case36: Female, Chinese, 9.3(end of study)

      NotHPOsFreeText: asymptomatic, no onset

      Case36 (Level 2)


      CasePreviousTesting: NBS

      CaseMethod1: same as group

      CaseMethod2: same as group

      CaseGenotypingMethod: same as group


      Variant1: NM_000255.3:c.1630_1631delGGinsTA (p.Gly544Ter)

      ClinVar: 203860

      CAID: CA312786

      gnomAD: 0.0001088 (East Asian)


      Variant2: NM_000255.3:c.1943G>A (p.Gly648Asp)

      ClinVar: n/a

      CAID: CA3846709

      gnomAD: 0.0001087 (East Asian)

      CaseAddInfo: heterozygous mutations in trans, but no symptoms. identical twin to Case35/P35.

    10. P35

      Case35: Female, Chinese, 9.3y (end of study)

      NotHPOsFreeText: asymptomatic, no onset

      Case35 (Level 2)


      CasePreviousTesting: NBS

      CaseMethod1: same as group

      CaseMethod2: same as group

      CaseGenotypingMethod: same as group


      Variant1: NM_000255.3:c.1630_1631delGGinsTA (p.Gly544Ter)

      ClinVar: 203860

      CAID: CA312786

      gnomAD: 0.0001088 (East Asian)


      Variant2: NM_000255.3:c.1943G>A (p.Gly648Asp)

      ClinVar: n/a

      CAID: CA3846709

      gnomAD: 0.0001087 (East Asian)

      CaseAddInfo: heterozygous mutations in trans, but no symptoms. identical twin to Case36/P36.

    11. P34

      Case34: Male, Chinese, 5.5y (end of study)

      HPOsFreeText: 2 mo onset, poor neurologic outcome

      NotHPOsFreeText: not responsive to vitamin B12

      Case34 (Level 2)


      CasePreviousTesting: same as group

      CaseMethod1: same as group

      CaseMethod2: same as group

      CaseGenotypingMethod: same as group


      Variant1: NM_000255.3:c.1630_1631delGGinsTA (p.Gly544Ter)

      ClinVar: 203860

      CAID: CA312786

      gnomAD: 0.0001088 (East Asian)


      Variant2: NM_000255.3:c.1880A>G (p.His627Arg)

      ClinVar: 551830

      CAID: CA3846719

      gnomAD: 0.00002639 (European non-Finnish)

      CaseAddInfo: heterozygous mutations in trans

    12. P33

      Case33: Male, Chinese, 1.8y (end of study)

      HPOsFreeText: Neonatal development

      NotHPOsFreeText: normal cognitive and motor development without further episodes of metabolic decompensation, not responsive to vitamin B12

      Case33 (Level 2)


      CasePreviousTesting: same as group

      CaseMethod1: same as group

      CaseMethod2: same as group

      CaseGenotypingMethod: same as group


      Variant1: NM_000255.3:c.1280G>A (p.

      ClinVar: 218990

      CAID: CA347873

      gnomAD: 0.0004011 (East Asian)


      CaseAddInfo: one variant, not homozygous

    13. P31

      Case31: Male, Chinese, 3.7y (end of study)

      HPOsFreeText: neonatal onset, poor neurological outcome

      NotHPOsFreeText: not responsive to vitamin B12

      Case31 (Level 2)


      CasePreviousTesting: same as group

      CaseMethod1: same as group

      CaseMethod2: same as group

      CaseGenotypingMethod: same as group


      Variant1: NM_000255.3:c.1106G>A (p.Arg369His)

      ClinVar: 203846

      CAID: CA312764

      gnomAD: 0.0001504 (East Asian)

      CaseAddInfo: one variant, not homozygous.

    14. P30

      Case30: Male, Chinese, 1 mo (age at death)

      HPOsFreeText: neonatal onset

      NotHPOsFreeText: not responsive to vitamin B12

      Case30 (Level 2)


      CasePreviousTesting: same as group

      CaseMethod1: same as group

      CaseMethod2: same as group

      CaseGenotypingMethod: same as group


      Variant1: NM_000255.3:c.925T>G (p.Trp309Gly)

      ClinVar: n/a

      CAID: CA364401026

      gnomAD: n/a


      Variant2: NM_000255.3:c.1630_1631delGGinsTA (p.Gly544Ter)

      ClinVar: 203860

      CAID: CA312786

      gnomAD: 0.0001088 (East Asian)


      CaseAddInfo: heterozygous mutations in trans, died at 1 mo

    15. P32

      Case32: Male, Chinese, 1.8y (end of study)

      HPOsFreeText: neonatal onset, poor neurological outcome

      NotHPOsFreeText: not responsive to vitamin B12

      Case32 (Level 2)


      CasePreviousTesting: same as group

      CaseMethod1: same as group

      CaseMethod2: same as group

      CaseGenotypingMethod: same as group


      Variant1: NM_000255.3:c.1280G>A (p.

      ClinVar: 218990

      CAID: CA347873

      gnomAD: 0.0004011 (East Asian)


      Variant2: NM_000255.3:c.1677-1G>A (p.=)

      ClinVar: 550012

      CAID: CA3846767

      gnomAD: 0.0003511 (East Asian)


      CaseAddInfo: heterozygous mutations in trans

    16. P29

      Case29: Male, Chinese, 3.2 y (end of study)

      HPOsFreeText: neonatal onset, poor neurological outcome

      NotHPOsFreeText: not responsive to vitamin B12

      Case29 (Level 2)


      CasePreviousTesting: NBS

      CaseMethod1: same as group

      CaseMethod2: same as group

      CaseGenotypingMethod: same as group


      Variant1: NM_000255.3:c.755dupA (p.His252GlinfsTer6)

      ClinVar: n/a

      CAID: CA3847037

      gnomAD: 0.0001090 (East Asian)


      Variant2: NM_000255.3:c.1741C>T (p.Arg581Ter)

      ClinVar: 554675

      CAID: CA364395893

      gnomAD: n/a


      CaseAddInfo: heterozygous mutations in trans

    17. P28

      Case28: Male, Chinese, 6.8y (end of study)

      HPOsFreeText: neonatal onset, poor neurological outcome

      NotHPOsFreeText: not responsive to vitamin B12

      Case28 (Level 2)


      CasePreviousTesting: same as group

      CaseMethod1: same as group

      CaseMethod2: same as group

      CaseGenotypingMethod: same as group


      Variant1: NM_000255.3:c.754-1G>A (p.=)

      ClinVar: n/a

      CAID: CA364402849

      gnomAD: n/a


      Variant2: NM_000255.3:c.1061C>T (p.Ser354Phe)

      ClinVar: n/a

      CAID: CA364400211

      gnomAD: n/a


      CaseAddInfo: heterozygous mutations in trans.

    18. P27

      Case27: Male, Chinese, 1.8y (end of study)

      HPOsFreeText: neonatal onset, poor neurological outcome

      NotHPOsFreeText: not responsive to vitamin B12

      Case27 (Level 2)


      CasePreviousTesting: same as group

      CaseMethod1: same as group

      CaseMethod2: same as group

      CaseGenotypingMethod: same as group


      Variant1: NM_000255.3:c.729_730insTT (p.Asp244LeufsTer?)

      ClinVar: 552079

      CAID: CA3847064

      gnomAD: 0.0002008 (East Asian)


      CaseAddInfo: one variant, not homozygous.

    19. P26

      Case26: Female, Chinese, 6.6y (end of study)

      HPOsFreeText: responsive to vitamin B12

      NotHPOSFreeText: asymptomatic, no onset

      Case26 (Level 2)


      CasePreviousTesting: NBS

      CaseMethod1: same as group

      CaseMethod2: same as group

      CaseGenotypingMethod: same as group


      Variant1: NM_000255.3:c.729_730insTT (p.Asp244LeufsTer?)

      ClinVar: 552079

      CAID: CA3847064

      gnomAD: 0.0002008 (East Asian)


      CaseAddInfo: one variant, not homozygous. asymptomatic.

    20. P25

      Case25: Male, Chinese, 3 mo (age at death)

      HPOsFreeText: neonatal onset

      NotHPOsFreeText: not responsive to vitamin B12

      Case25 (Level 2)


      CasePreviousTesting: NBS

      CaseMethod1: same as group

      CaseMethod2: same as group

      CaseGenotypingMethod: same as group


      Variant1: NM_000255.3:c.729_730insTT (p.Asp244LeufsTer?)

      ClinVar: 552079

      CAID: CA3847064

      gnomAD: 0.0002008 (East Asian)


      Variant2: NM_000255.3:c.1630_1631delGGinsTA (p.Gly544Ter)

      ClinVar: 203860

      CAID: CA312786

      gnomAD: 0.0001088 (East Asian)

      CaseAddInfo: heterozygous mutations in trans. died at 3 mo.

    21. P24

      Case24: Male, Chinese, 6.5y (end of study)

      HPOsFreeText: neonatal onset, poor neurological outcome

      NotHPOsFreeText: not responsive to vitamin B12

      Case24 (Level 2)


      CasePreviousTesting: same as group

      CaseMethod1: same as group

      CaseMethod2: same as group

      CaseGenotypingMethod: same as group


      Variant1: NM_000255.3:c.729_730insTT (p.Asp244LeufsTer?)

      ClinVar: 552079

      CAID: CA3847064

      gnomAD: 0.0002008 (East Asian)


      Variant2: NM_000255.3:c.1540C>A (p.Gln514Lys)

      ClinVar: n/a

      CAID: CA364397122

      gnomAD: n/a

      CaseAddInfo: heterozygous mutations in trans. Variant 2 is novel

    22. P23

      Case23: Female, Chinese, 3y (end of study)

      HPOsFreeText: 1.8y onset, poor neurological outcome

      NotHPOsFreeText: not responsive to vitamin B12

      Case23 (Level 2)


      CasePreviousTesting: same as group

      CaseMethod1: same as group

      CaseMethod2: same as group

      CaseGenotypingMethod: same as group


      Variant1: NM_000255.3:c.729_730insTT (p.Asp244LeufsTer?)

      ClinVar: 552079

      CAID: CA3847064

      gnomAD: 0.0002008 (East Asian)


      Variant2: NM_000255.3:c.1295A>C (p.Glu432Ala)

      ClinVar: n/a

      CAID: CA364398703

      gnomAD: n/a

      CaseAddInfo: heterozygous mutations in trans

    23. P22

      Case22: Female, Chinese, 1.3y (end of study)

      HPOsFreeText: 11 mo onset, poor neurological outcome

      NotHPOsFreeText: not responsive to vitamin B12

      Case22 (Level 2)


      CasePreviousTesting: same as group

      CaseMethod1: same as group

      CaseMethod2: same as group

      CaseGenotypingMethod: same as group


      Variant1: NM_000255.3:c.729_730insTT (p.Asp244LeufsTer?)

      ClinVar: 552079

      CAID: CA3847064

      gnomAD: 0.0002008 (East Asian)


      Variant2: NM_000255.3:c.1106G>A (p.Arg369His)

      ClinVar: 203846

      CAID: CA312764

      gnomAD: 0.0001504 (East Asian)

      CaseAddInfo: heterozygous mutations in trans

    24. P21

      Case21: Male, Chinese, 9 mo (age at death)

      HPOsFreeText: neonatal onset

      NotHPOsFreeText: not responsive to vitamin B12

      Case21 (Level 2)


      CasePreviousTesting: same as group

      CaseMethod1: same as group

      CaseMethod2: same as group

      CaseGenotypingMethod: same as group


      Variant1: NM_000255.3:c.729_730insTT (p.Asp244LeufsTer?)

      ClinVar: 552079

      CAID: CA3847064

      gnomAD: 0.0002008 (East Asian)


      Variant2: NM_000255.3:c.1106G>A (p.Arg369His)

      ClinVar: 203846

      CAID: CA312764

      gnomAD: 0.0001504 (East Asian)

      CaseAddInfo: heterozygous mutations in trans, died at 9 mo

    25. P20

      Case20: Female, Chinese, 1 y (end of study)

      HPOsFreeText: neonatal onset, poor neruological outcome

      NotHPOsFreeText: not responsive to vitamin B12

      Case20 (Level 2)


      CasePreviousTesting: same as group

      CaseMethod1: same as group

      CaseMethod2: same as group

      CaseGenotypingMethod: same as group


      Variant1: NM_000255.3:c.729_730insTT (p.Asp244LeufsTer?)

      ClinVar: 552079

      CAID: CA3847064

      gnomAD: 0.0002008 (East Asian)


      Variant2: NM_000255.3:c.1105C>T (p.Arg369Cys)

      ClinVar: 218989

      CAID: CA347895

      gnomAD: 0.00006536 (South Asian)


      CaseAddInfo: heterozygous mutations in trans

    26. P19

      Case19: Female, Chinese, 2.4 y (end of study)

      HPOsFreeText: 1.8 y onset

      NotHPOsFreeText: normal cognitive and motor development without further episodes of metabolic decompensation, not responsive to vitamin B12

      Case19 (Level 2)


      CasePreviousTesting: same as group

      CaseMethod1: same as group

      CaseMethod2: same as group

      CaseGenotypingMethod: same as group


      Variant1: NM_000255.3:c.655A>G (p.Asn219Asp)

      ClinVar: n/a

      CAID: CA364404270

      gnomAD: n/a


      Variant2: NM_000255.3:c.729_730insTT (p.Asp244LeufsTer?)

      ClinVar: 552079

      CAID: CA3847064

      gnomAD: 0.0002008 (East Asian)


      CaseAddInfo: heterozygous mutations in trans

    27. P17

      Case17: Male, Chinese, 6.5y (end of study)

      HPOsFreeText: neonatal onset

      NotHPOsFreeText: not responsive to vitamin B12, normal cognitive and motor development without further episodes of metabolic decompensation

      Case17 (Level 2)


      CasePreviousTesting: same as group

      CaseMethod1: same as group

      CaseMethod2: same as group

      CaseGenotypingMethod: same as group


      Variant1: NM_000255.3:c.554C>T (p.Ser185Phe)

      ClinVar: n/a

      CAID: CA364404475

      gnomAD: n/a


      Variant2: NM_000255.3:c.2062G>T (p.Glu688Ter)

      ClinVar: n/a

      CAID: CA3846672

      gnomAD: 0.00006152 (African)


      CaseAddInfo: heterozygous mutations in trans.

    28. P16

      Case16: Male, Chinese, 2.4 y (end of study)

      HPOsFreeText: neonatal onset, poor neurological outcome

      NotHPOsFreeText: not responsive to vitamin B12

      Case16 (Level 2)


      CasePreviousTesting: same as group

      CaseMethod1: same as group

      CaseMethod2: same as group

      CaseGenotypingMethod: same as group


      Variant1: NM_000255.3:c.454C>T (p.Arg152Ter)

      ClinVar: 426467

      CAID: CA3847107

      gnomAD: 0.00009813 (South Asian)


      Variant2: NM_000255.3:c.1280G>A (p.Gly427Asp)

      ClinVar: 218990

      CAID: CA347873

      gnomAD: 0.0004011 (East Asian)


      CaseAddInfo: heterozygous mutations in trans.

    29. P18

      Case18: Male, Chinese, 5 mo (age at death)

      HPOsFreeText: neonatal onset

      NotHPOsFreeText: not responsive to vitamin B12

      Case18 (Level 2)


      CasePreviousTesting: same as group

      CaseMethod1: same as group

      CaseMethod2: same as group

      CaseGenotypingMethod: same as group


      Variant1: NM_000255.3:c.626dupC

      ClinVar: n/a

      CAID: CA825482501

      gnomAD: n/a


      Variant2: NM_000255.3:c.1531C>T (p.Arg511Ter)

      ClinVar: 556124

      CAID: CA3846855

      gnomAD: 0.00003270 (South Asian)


      CaseAddInfo: variant 1 is novel. Heterozygous mutations in trans.

    30. P15

      Case15: Male, Chinese, 6 mo (age at death)

      HPOsFreeText: neonatal onset

      NotHPOsFreeText: not responsive to vitamin B12

      Case15 (Level 2)


      CasePreviousTesting: same as group

      CaseMethod1: same as group

      CaseMethod2: same as group

      CaseGenotypingMethod: same as group


      Variant1: NM_000255.3:c.433G>A (p.Gly145Ser)

      ClinVar: n/a

      CAID: CA364404739

      gnomAD: n/a


      Variant2: NM_000255.3:c.1677-1G>A (p.=)

      ClinVar: 550012

      CAID: CA3846767

      gnomAD: 0.0003511 (East Asian)


      CaseAddInfo: heterozygous mutations in trans. Died at 6 mo.

    31. P14

      Case14: Male, Chinese, 2.4 y (onset)

      HPOsFreeText: 2.4 y onset

      NotHPOsFreeText: not responsive to vitamin B12

      Case14 (Level 2)


      CasePreviousTesting: same as group

      CaseMethod1: same as group

      CaseMethod2: same as group

      CaseGenotypingMethod: same as group


      Variant1: NM_000255.3:c.421G>A (p.Ala141Thr)

      ClinVar: 557678

      CAID: CA364404763

      gnomAD: n/a


      Variant2: NM_000255.3:c.810_811dupGG (p.?)

      ClinVar: n/a

      CAID: CA3847032

      gnomAD: n/a


      CaseAddInfo: lost to follow up. heterozygous mutations in trans. both novel mutations

    32. P12

      Case12: Female, Chinese, 1.5 y (end of study)

      HPOsFreeText: 11 mo onset, poor neruological outcome

      NotHPOsFreeText: not responsive to vitamin B12


      Case 12 (Level 2)

      CasePreviousTesting: same as group

      CaseMethod1: same as group

      CaseMethod2: same as group

      CaseGenotypingMethod: same as group


      Variant1: NM_000255.3:c.323G>A (p.Arg108His)

      ClinVar: 100707

      CAID: CA235522

      gnomAD: 0.00006152 (African)


      Variant2: NM_000255.3:c.2179C>T (p.Arg727Ter)

      ClinVar: 218998

      CAID: CA347913

      gnomAD: 0.0001504 (East Asian)


      CaseAddInfo: heterozygous mutations in trans

    33. P11

      Case11: Female, Chinese, 2 y (age at death)

      HPOsFreeText: 9 mo onset, responsive to vitamin B12


      Case11 (Level 2)

      CasePreviousTesting: same as group

      CaseMethod1: same as group

      CaseMethod2: same as group

      CaseGenotypingMethod: same as group


      Variant1: NM_000255.3(MMUT):c.323G>A (p.Arg108His)

      ClinVar: 100707

      CAID: CA235522

      gnomAD: 0.00006152 (African)


      Variant2: NM_000255.3:c.1514T>C (p.!le505Thr)

      ClinVar: n/a

      CAID: CA364397174

      gnomAD: n/a


      CaseAddInfo: heterozygous mutations in trans, died at 2 y

    34. P10

      Case10: Male, Chinese, 6.4 y (onset)

      HPOsFreeText: 6.4 y onset

      NotHPOsFreeText: not responsive to vitamin B12


      Case10 (Level 2)

      CasePreviousTesting: same as group

      CaseMethod1: same as group

      CaseMethod2: same as group

      CaseGenotypingMethod: same as group


      Variant1: NM_000255.3(MMUT):c.323G>A (p.Arg108His)

      ClinVar: 100707

      CAID: CA235522

      gnomAD: 0.00006152 (African)


      Variant2: NM_000255.3:c.729_730insTT (p.Asp244LeufsTer?)

      ClinVar: 552079

      CAID: CA3847064

      gnomAD: 0.0002008 (East Asian)


      CaseAddInfo: lost to follow up, heterozygous mutations in trans

    35. P13

      Case13: Female, Chinese, 7 mo (onset)

      HPOsFreeText: 7 mo onset

      NotHPOsFreeText: not responsive to vitamin B12


      Case13 (Level 2):

      CasePreviousTesting: same as group

      CaseMethod1: same as group

      CaseMethod2: same as group

      CaseGenotypingMethod: same as group


      Variant1: NM_000255.3:c.419T>C (p.Leu140Pro)

      ClinVar: n/a

      CAID: CA364404765

      gnomAD: n/a


      Variant2: NM_000255.3:c.424A>G (p.Thr142Ala)

      ClinVar: n/a

      CAID: CA364404758

      gnomAD: n/a


      CaseAddInfo: Variant 1 is novel. Heterozygous mutations in trans. lost to follow up.

    36. P9

      Case1: Male, Chinese, 1.8 y (end of study)

      HPOsFreeText: neonatal onset, poor neurological outcome

      NotHPOsFreeText: not responsive to vitamin B12


      Case9 (Level 2)

      CasePreviousTesting: same as group

      CaseMethod1: same as group

      CaseMethod2: same as group

      CaseGenotypingMethod: same as group


      Variant1: NM_000255.3:c.322C>T (p.Arg108Cys)

      ClinVar: 1887

      CAID: CA249732

      gnomAD: 0.0008393 (Latino)


      Variant2: NM_000255.3(MMUT):c.323G>A (p.Arg108His)

      ClinVar: 100707

      CAID: CA235522

      gnomAD: 0.00006152 (African)


      Variant3: NM_000255.3:c.2168G>A (p.Gly723Asp)

      ClinVar: n/a

      CAID: CA3846630

      gnomAD: 0.00006533 (South Asian)


      CaseAddInfo: Variant 1 in trans to Variants 2 and 3 (cis). Variant 3 is novel

    37. P8

      Case8: Male, Chinese, 8 mo (onset)

      HPOsFreeText 8 mo onset, responsive to vitamin B12

      Case8 (Level 2)


      CasePreviousTesting: same as group

      CaseMethod1: same as group

      CaseMethod2: same as group

      CaseGenotypingMethod: same as group


      Variant1: NM_000255.3:c.278G>A (p.Arg93His)

      ClinVar: 1880

      CAID: CA249728

      gnomAD: 0.0004777 (European-Finnish)


      Variant2: NM_000255.3:c.567T>G (p.Asn189Lys)

      ClinVar: 618734

      CAID: CA364404447

      gnomAD: n/a


      CaseAddInfo: lost to follow up, heterozygous mutations in trans

    38. P7

      Case7: Male, Chinese, 33 d (age at death)

      HPOsFreeText: Neonatal onset

      NotHPOsFreeText: Not responsive to vitamin B12

      Case7 (Level 2)


      CasePreviousTesting: Same as group

      CaseMethod1: same as group

      CaseMethod2: same as group

      CaseGenotypingMethod: same as group


      Variant1: NM_000255.3:c.103C>T (p.Gln35Ter)

      ClinVar: n/a

      CAID: CA364405751

      gnomAD: 0.00009950 (Ashkenazi Jewish)


      Variant2: NM_000255.3:c.494A>G (p.Asp165Gly)

      ClinVar: n/a

      CAID: CA138799926

      gnomAD: 0.00005443 (East Asian)


      CaseAddInfo: died at 33d, heterozygous mutations in trans

    39. P6

      Case6: Female, Chinese, 1 mo (onset)

      HPOsFreeText: not responsive to vitamin B12

      Case6 (Level 2)


      CasePreviousTesting: same as group

      CaseMethod1: same as group

      CaseMethod2: same as group

      CaseGenotypingMethod: same as group


      Variant1: NM_000255.3:c.68C>G (p.Ser23Ter)

      ClinVar: n/a

      CAID: CA364405860

      gnomAD: n/a


      Variant2: NM_000255.3:c.323G>A (p.Arg108His)

      ClinVar: 100707

      CAID: CA235522

      gnomAD: 0.00006152 (African)


      CaseAddInfo: lost to follow up, heterozygous mutations in trans

    40. 43 patients

      GroupPresentingHPOs: HP:0001987, HP:0001942, HP:0003128, HP:0002912 (hyperammonemia, metabolic acidosis, lactic acidosis, methylmalonic acidemia)

      HPOsFreeText: elevated blood levels of propionylcarnitine (C3) (median 13.56 umol/L), and elevated C3 to acetylcarnitine (C2) ratio (median 0.85). elevated urine methylmalonate levels (median 598.96 mmol/mol creatinine). 28/73.7% displayed recurrent vomiting (HP:0002572). 28/73.7% displayed disturbances of consciousness (HP:0004372). 23/60.5% displayed feeding difficulties in infancy (HP:0008872), 20/52.6% displayed respiratory distress (HP:0002098), 20/52.6% displayed failure to thrive (HP:0001508), 20/52.6% displayed dystonia (HP:0001332), 14/36.8% displayed mental retardation, 12/31.6% displayed convulsions.

      GroupNotHPOs: normal plasma total homocysteine

      NotHPOsFreeText:

      NumberMales: 27

      NumberFemales: 16

      CountryOrigin: China

      Ethnicity: Chinese

      AgeRange: 33d- 10.3 y at last follow up

      TotalNumber 43

      FamilyInfo: 43

      NoFamily: 0

      GroupAddInfo: 9 identified by NBS, 34 recruited after being suspected of inherited metabolism disorders. 42 families from 14 provinces of the Mainland of China. 8 died during acute metabolic crisis, 7 lost to follow up, 28 alive at end of study.

      Group (Level 2)


      VariantCount: 43 (35 had two mutant alleles)

      NonVariant: 0

      OtherVariant: 0

      GroupPreviousTesting: tandem mass spectrometry for blood levels, gas chromatography-mass spectrometry for urine,

      GroupMethod1: PCR

      GroupGenotypingMethod: genomic DNA extracted from peripheral blood leukocytes from patients and their parents. Exonic and flanking intronic regions of the MUT gene were amplified through PCR. PCR products were sequenced directly using forward and reverse primers on ABI 3700 sequencer. Mutation analysis using MUT reference NM_000255.3. Nucleotide numbering reflects cDNA numbering (initiation codon= codon1). All detected mutations were confirmed in the patients' parents. Novel variants were screened in 100 alleles from 50 control children. Novel variants were considered pathogenic when predicted to be deleterious by two algorithms.

    41. P1

      Case1: Male, Chinese, 11 mo (at end of study)

      Case1HPOs: HP:0012736 (profound psychomotor retardation)

      HPOsFreeText: 10 mo at onset, poor neurological outcome

      NotHPOsFreeText: not responsive to vitamin B12


      Case1 (Level 2)

      CasePreviousTesting: same as group

      CaseMethod1: same as group

      CaseMethod2: same as group

      CaseGenotypingMethod: same as group


      Variant: NM_000255.3(MMUT):c.323G>A (p.Arg108His)

      ClinVar: 100707

      CAID: CA235522

      gnomAD: 0.00006152 (African)


      CaseAddInfo: homozygous mutations

    42. P4

      Case4: Male, Chinese, 2.8 y (end of study)

      HPOsFreeText: poor neurologic outcome, neonatal onset

      NotHPOsFreeText: not responsive to vitamin B12


      Case4 (Level 2):

      CasePreviousTesting: NBS

      CaseMethod1: same as group

      CaseMethod2: same as group

      CaseGenotypingMethod: same as group


      Variant: NM_000255.3:c.729_730insTT (p.Asp244LeufsTer?)

      ClinVar: 552079

      CAID: CA3847064

      gnomAD: 0.0002008 (East Asian)


      CaseAddInfo: homozygous mutations

    43. P5

      Case5: Female, Chinese, 1.6 y (onset)

      HPOsFreeText: 1.6 y onset

      NotHPOsFreeText: Not responsive to vitamin B12


      Case5 (Level 2):

      CasePreviousTesting: same as group

      CaseMethod1: same as group

      CaseMethod2: same as group

      CaseGenotypingMethod: same as group


      Variant: NM_000255.3:c.1106G>A (p.Arg369His)

      ClinVar: 203846

      CAID: CA312764

      gnomAD: 0.0001504 (East Asian)


      CaseAddInfo: homozygous mutations, lost to follow up

    44. P3

      Case3: Female, Chinese, 4 mo (end of study)

      HPOsFreeText: Responsive to vitamin B12


      Case3 (Level 2):

      CasePreviousTesting: NBS

      CaseMethod1: same as group

      CaseMethod2: same as group

      CaseGenotypingMethod: same as group


      Variant: NM_000255.3:c.599T>C (p.Ille200Thr)

      ClinVar: n/a

      CAID: CA364404381

      gnomAD: n/a


      CaseAddInfo: homozygous mutations, asymptomatic

    45. P2

      Case2: Male, Chinese, 3 mo (age at death)

      HPOsFreeText: Neonatal onset

      NotHPOsFreeText: Not responsive to vitamin B12


      Case2 (Level 2):

      CasePreviousTesting: NBS (newborn screening)

      CaseMethod1: same as group

      CaseMethod2: same as group

      CaseGenotypingMethod: same as group


      Variant: NM_000255.3:c.482G>T (p.Gly161Val)

      ClinVar: n/a

      CAID: CA364404636

      gnomAD: n/a


      CaseAddInfo: homozygous mutations, novel mutation

    1. Patient 2

      Case2: Female, Iran, 18 mo (age at diagnosis)

      CasePresentingHPOs: HP:0003324, HP:0001254, HP:0004789, HP:0002039, HP:0002015, HP:0002098, HP:0001508, HP:0002360, HP:0001298 (generalized muscle weakness, lethargy, milk intolerance, anorexia, swallowing difficulty, breathing difficulties, failure to thrive, sleep disturbance, encephalopathy)

      HPOsFreeText: unspecified abnormalities in sitting and speech

      Case (Level 2)


      CasePreviousTesting: elevated propionylcarnitines (4.24 umol/L), Urine MMA (BT) 2200 umol/mmol creatinine, Urine MMA (AT) 40.0 umol/mmol creatinine

      CaseMethod1: same as group

      CaseGenotypingMethod: same as group


      Variant: NM_000255.3:c.2125-3C>G

      ClinVar: n/a

      CAID: CA913187295

      gnomAD: n/a


      CaseAddInfo: consanguineous parents. Treated for MMA with L-carnitine, biotin, and vitamin B12. Died at the age of 3.5 y. homozygous mutation.

    2. Patient 3

      Case3: Female, Iran, 3 d (age at diagnosis)

      CasePresentingHPOs: HP:0002883, HP:0001254, HP:0004789, HP:0002039, HP:0001290, HP:0001941, HP:0001508, HP:0001298, HP:0002019 (rapid breathing, lethargy, milk intolerance, anorexia, hypotonia, acidosis, failure to thrive, encephalopathy, constipation)

      Case (Level 2)


      CasePreviousTesting: elevated propionylcarnitine (61 umol/L), Urine MMA (BT) 1950 umol/mmol creatinine, Urine MMA (AT) 35.0 umol/mmol creatinine.

      CaseMethod1: same as group

      CaseGenotypingMethod: same as group


      Variant: NM_000255.3:c.2125-3C>G

      ClinVar: n/a

      CAID: CA913187295

      gnomAD: n/a


      CaseAddInfo: Consanguineous parents. Treated for MMA with L-carnitine, sodium benzoate, and vitamin B12. Currently 6 y, with moderately delayed development. Deceased infant sibling with similar symptoms, not genotyped. homozygous mutation.

    3. Three unrelated affected patients

      GroupPresentingHPOs: HP:0002013, HP:0001263 (vomiting, developmental delay)

      HPOsFreeText: increased urinary excretion of methylmalonate and methylcitric acids. Elevated propionylcarnitine.

      NumberMales: 0

      NumberFemales: 3

      CountryOrigin: Iran

      AgeRange: 3 d-22 mo (age at diagnosis)

      TotalNumber: 3

      FamilyInfo: 3

      NoFamily: 0

      GroupAddInfo: All probands are products of consanguineous marriages.

      Group (Level 2)


      VariantCount: 3

      NonVariant: 0

      OtherVariant: 0

      GroupPreviousTesting: urine organic acid analysis with urease treatment extraction with gas chromatography-mass spectrometry, after showing high levels of propionylcarnitine (umol/L) through tandem mass spectrometry

      GroupMethod1: PCR

      GroupGenotypingMethod: Genomic DNA was extracted from peripheral blood samples by the salting out method. MUT gene was analyzed by PCR and sequencing of both DNA strands of the entire coding region and highly-conserved exon-intron splice junctions. Reference sequence is NM_000255.3. Amplification was confirmed by electrophoresis, and products of the sequencing reaction were analyzed by DNA Sequencher 4.7. The phase of the mutation was confirmed by sequencing DNA from the patients parents.

    4. Patient 1

      Case1: Female, Iran, 22 mo (age at diagnosis)

      CasePresentingHPOs: HP:0001250, HP:0001290, HP:0001941, HP:0002019, HP:0002355, HP:0001344 (seizures, generalized hypotonia, acidosis, constipation, difficulty walking, absent speech)

      HPOsFreeText: congenital malformations

      Case (Level 2)


      CasePreviousTesting: elevation of propionylcarnitine (9.8 umol/L0, Urine MMA (BT) 2800 umol/mmol creatinine, Urine MMA (AT) 47.0 umol/mmol creatinine

      CaseMethod1: same as group

      CaseGenotypingMethod: same as group


      Variant: NM_000255.3:c.2125-3C>G

      ClinVar: n/a

      CAID: CA913187295

      gnomAD: n/a


      CaseAddInfo: consanguineous parents, treated for MMA with phenobarbital, L-carnitine, and vitamin B12. Died at 3 y of age. homozygous mutation.